Dr. BS Ajaikumar has launched the Inviga Healthcare Fund in conjunction with his first $2 million investment in Mynvax, a biotech start-up that is leading the way in developing recombinant vaccines for respiratory viral infections like COVID-19 and influenza.
Dr. Ajaikumar highlighted the goal of Inviga Health Fund, which is to empower physicians and healthcare entrepreneurs while democratizing access to high-quality healthcare, while sharing his own experiences with the healthcare system. He sees this project serving as a catalyst for developing sustainable healthcare firms, encouraging social impact, and nurturing clinical excellence.
Inviga is prepared to assist businesses in the pharmaceutical, life sciences, and healthcare sectors. The fund seeks to foster a vibrant ecosystem of Indian healthcare entrepreneurs while advancing innovation and driving improved outcomes through the use of its extensive industry insights, global network, and multidisciplinary experience.
Source : The Hindu Business Line
